Current trends in the management of pancreatic cystic neoplasms in Korea: a national survey
- Author:
Hyung Ku CHON
1
;
Sung Hoon MOON
;
Sang Wook PARK
;
Woo Hyun PAIK
;
Chang Nyol PAIK
;
Byoung Kwan SON
;
Tae Jun SONG
;
Dong Won AHN
;
Eaum Seok LEE
;
Yun Nah LEE
;
Yoon Suk LEE
;
Jae Min LEE
;
Tae Joo JEON
;
Chang-Hwan PARK
;
Kwang Bum CHO
;
Dong Wook LEE
Author Information
- Publication Type:2
- From:The Korean Journal of Internal Medicine 2022;37(1):63-72
- CountryRepublic of Korea
- Language:English
-
Abstract:
Background/Aims:The study aimed to investigate the current practice patterns in the management of pancreatic cystic neoplasms in Korea.
Methods:An electronic survey was systematically distributed by email to members of the Korean Pancreatobiliary Association from December 2019 to February 2020.
Results:In total, 115 (110 gastroenterologists, five surgeons) completed the survey, 72.2% of whom worked in a tertiary/academic medical center. Most (65.2%) followed the 2012/2017 International Association of Pancreatology guidelines for the management of pancreatic cystic neoplasms. A gadolinium-enhanced magnetic resonance imaging/magnetic resonance cholangiopancreatography was the most common first-line diagnostic modality (42.1%), but a contrast-enhanced computed tomography scan was preferred as a subsequent surveillance tool (58.3%). Seventy- four percent of respondents routinely performed endoscopic ultrasound-guided fine needle aspiration for pancreatic cystic neoplasms with suspicious mural nodules. Endoscopic ultrasound-guided fine needle aspiration cytology (94.8%) and cystic fluid carcinoembryonic antigen (95.7%) were used for cystic fluid analysis. Most (94%) typically recommended surgery in patients with high-risk stigmata, but 18.3% also considered proceeding with surgery in patients with worrisome features. Most (96.5%) would continue surveillance of pancreatic cystic neoplasms for more than 5 years.
Conclusions:According to this survey, there was variability in the management of pancreatic cystic neoplasms among the respondents. These results suggest that the development of evidence-based guidelines for pancreatic cystic neoplasms that fit the Korean practice is needed to create an optimal approach to the management of pancreatic cystic neoplasms.
